Coming soon: news reporting from IAS 2017

Amelia Jones
Published: 10 July 2017

The 9th IAS Conference on HIV Science (IAS 2017), organised by the International AIDS Society, is taking place in Paris, France, from 23-26 July 2017.

NAM is delighted to be the official provider of online scientific news reporting for the conference.

We’ll be reporting on key research presented at the conference, publishing news online and sending out conference news summary bulletins during the week of the conference, and one in the week following the conference. The bulletins will be available in English, French, Spanish, Portuguese, Italian and Russian. You can sign up here to receive these email bulletins. If you already receive NAM’s regular email bulletins, you will automatically receive our conference bulletins.

All of our news stories from IAS 2017 will be published on our conference webpages: www.aidsmap.com/ias2017

9th IAS Conference on HIV Science

The IAS Conference is the largest open scientific conference on HIV and AIDS related issues. The conference co-chairs say the conference brings together “a broad cross-section of more than 6,000 professionals from around the world to meet and examine the latest scientific developments in HIV-related research with a focus on moving science into practice and policy.”

This year’s conference will feature new research on:

  • Pre-exposure prophylaxis (PrEP): evidence on long-term effectiveness, new formulations and user preferences.
  • HIV eradication: can the reservoir of HIV-infected cells be reduced by new approaches?
  • What do cancer research and HIV cure research have to teach other?
  • Self-testing: what impact does self-testing have on improving knowledge of HIV status?
  • New drug combinations for first-line treatment.
  • Prevention for adolescents.

For more information on the conference, visit the official IAS 2017 website: www.ias2017.org. You can also view the conference programme online, where you will find details on conference sessions, abstracts, exhibits and IAS 2017 events.

Sharing knowledge, changing lives

NAM works to change lives by sharing information about HIV and you can help by sharing links to the research presented at the conference. So please feel free to use links to our news stories, bulletins and any other aidsmap.com pages – in emails, newsletters and blogs or in other social media like Facebook and Twitter.

If you would like to feature our conference news on your website, or receive it in a newsreader, visit the news feeds section of our conference webpages for more information and RSS feeds.

Before the conference begins you can help us by letting your contacts know they can sign up to receive the free conference bulletins at www.aidsmap.com/ias2017

Download our news app to keep up to date

As well as accessing news from IAS 2017 through our website, you can also download our free app for iPhone or Android.

The apps link to our daily news reports on new research presented at IAS 2017, and other news on HIV treatment and prevention. We also cover key developments in hepatitis, TB and other health conditions linked to HIV.

As well as articles by our own editors, the apps include a daily hand-picked selection of HIV-related stories from other websites around the world.

HIV Community Forum

NAM is hosting an HIV Community Forum in London on Thursday 3 August, from 6-9pm to share information on HIV treatment and prevention presented at IAS 2017.

The forum is free of charge and there are a limited number of places available. You can book your free place on the Eventbrite website.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.